Australia's CSL is wielding the axe, cutting its workforce by 15% – around 3,000 positions – while announcing plans to spin its vaccines unit into a standalone company. The decision to demerge the CSL ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Japan’s medicines regulator has approved the first vaccine based on self-assembling RNA, a spin on the mRNA technology used in current shots, which is designed to deliver greater efficacy with a lower ...

BMW's M division has a new halo car, and it also revives a legendary nameplate. The original BMW 3.0 CSL was a homologation special from the early 1970s, and the 'L' in its name came to signify ...

The chooks discuss whether Elon Musk can pull off the biggest float in history, how the budget is hitting house prices, and answer your tax change questions. The logistics company became the latest ...

CSL is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of CSL shares has increased $3.38 since the market last closed. This is a 1.03% ...

MELBOURNE, Aug. 19, 2025 /PRNewswire/ -- Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...